Icon Q1 2025 Earnings Preview
This Saia Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
Icon Cut to Neutral From Overweight by JP Morgan
Icon Price Target Cut to $150.00/Share From $265.00 by JP Morgan
J.P. Morgan Downgrades Icon PLC(ICLR.US) to Hold Rating, Cuts Target Price to $150
ICON Earnings Preview: Recent $ICLR Insider Trading, Hedge Fund Activity, and More
Goldman Sachs: The Q1 performance of U.S. pharmaceutical stocks is reassuring, and the Industry sentiment is slightly becoming more positive.
Goldman Sachs stated that amid cautious sentiment from investors towards the USA pharmaceutical sector before the Earnings Reports season, the performance of USA pharmaceutical companies that have reported results so far for the first quarter has not been worse than expected, and in some cases, it has even exceeded expectations.
ICON Public Limited Company (ICLR): Among the Oversold Growth Stocks to Buy Now
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Earnings Preview: Icon PLC to Report Financial Results Post-market on April 30
Is ICON Public Limited Company (NASDAQ:ICLR) Potentially Undervalued?
Jefferies Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $190
Express News | ICON PLC : Jefferies Cuts Target Price to $190 From $252
Take Care Before Jumping Onto ICON Public Limited Company (NASDAQ:ICLR) Even Though It's 25% Cheaper
Leerink Partners Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $235
TD Cowen Downgrades Icon PLC(ICLR.US) to Hold Rating, Cuts Target Price to $157
BofA Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $204
Icon Cut to Hold From Buy by TD Cowen
Icon Price Target Cut to $157.00/Share From $254.00 by TD Cowen
BofA Securities Cuts Price Target on ICON to $204 From $255